| CTRI Number |
CTRI/2024/10/074564 [Registered on: 01/10/2024] Trial Registered Prospectively |
| Last Modified On: |
26/09/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cohort Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Exploring the outcome of Combined Ayurvedic Treatments on Chronic Kidney Disease patients: An Observational study |
|
Scientific Title of Study
|
An observational study to explore the outcome of multimodal Ayurveda treatment in the management of chronic kidney disease-A prospective cohort study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Anuradha |
| Designation |
MD Scholar, Department of Kayachikitsa |
| Affiliation |
All India Institute Of Ayurveda |
| Address |
618(Seminar Hall) Department Of Kayachikitsa All India Institute Of Ayurveda Gautampuri Sarita vihar New Delhi
South
DELHI
110076
India
South DELHI 110076 India |
| Phone |
8587899505 |
| Fax |
|
| Email |
anu278388@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DrVG Huddar |
| Designation |
Additional Professor |
| Affiliation |
All India Institute Of Ayurveda |
| Address |
621 Department Of Kayachikitsa All India Institute Of Ayurveda Gautampuri Sarita vihar New Delhi
South
DELHI
110076
India
South DELHI 110076 India |
| Phone |
9986697942 |
| Fax |
|
| Email |
drvghuddar@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DrVG Huddar |
| Designation |
Additional Professor |
| Affiliation |
All India Institute Of Ayurveda |
| Address |
621 Department Of Kayachikitsa All India Institute Of Ayurveda Gautampuri Sarita vihar New Delhi
South
DELHI
110076
India
South DELHI 110076 India |
| Phone |
9986697942 |
| Fax |
|
| Email |
drvghuddar@gmail.com |
|
|
Source of Monetary or Material Support
|
| All India Institute Of Ayurveda
Gautampuri Sarita Vihar New Delhi
South
DELHI
110076
India |
|
|
Primary Sponsor
|
| Name |
All India Institute Of Ayurveda |
| Address |
Gautampuri Sarita Vihar New Delhi 110076 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Anuradha |
All India Institute Of Ayurveda |
OPD No. 5 (Integrative Nephrology Unit-Kayachikitsa)
Department of Kayachikitsa All India Institute Of Ayurveda South DELHI |
8587899505
anu278388@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| All India Institute Of Ayurveda Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N189||Chronic kidney disease, unspecified. Ayurveda Condition: MUTRAGHATAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details |
|
|
|
Inclusion Criteria
|
| Age From |
21.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1.Diagnosed cases of CKD with classical signs and symptoms.
2.According to International Classification of Disease 11th Revision (ICD-11) guidelines:-
GB61 Chronic kidney disease
GB61.0 Chronic kidney disease, stage 1
GB61.1 Chronic kidney disease, stage 2
GB61.2 Chronic kidney disease, stage 3a
GB61.3 Chronic kidney disease, stage 3b
GB61.4 Chronic kidney disease, stage 4
GB61.5 Chronic kidney disease, stage 5
|
|
| ExclusionCriteria |
| Details |
1.Patients present with complain of Tuberculosis, Carcinoma ,Pregnant and lactating mother.
2.Patient with Hepatorenal Syndrome.
3.Patient with uncontrolled Diabetes Mellitus and Hypertension.
4.Patient with Ischemic heart disease and other conditions which may become an outliers due to differed response
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Changes in the Renal function test and clinical symptoms of CKD after observing for 12weeks |
day0
day15
day30
day45
day60
day75
day90 |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Changes in the Quality of life, after observing for 12weeks.
2. Come up with the draft suggesting the trend of present clinical practice in CKD and further may help for developing a protocol.
3.To compare the safety parameters in terms of hemogram, LFT and KFT in pre and post treatment.
|
day0
day15
day30
day45
day60
day75
day90 |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
09/10/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [anu278388@gmail.com].
- For how long will this data be available start date provided 07-06-2026 and end date provided 07-06-2029?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
|
Brief Summary
|
Chronic Kidney Disease(CKD) is worldwide threat to public health and multiply risk on major non-communicable diseases, including CVD , DM Type 1 & 2 . However , with ageing CKD become a leading cause of mortality. In India, the annual prevalence of CKD is 800 per million population (pmp), and the incidence of end-stage renal disease (ESRD) is 150–200 pmp. with majority of the patients requiring hemodialysis and transplant, this poses significant financial burden over the affected families with approximately 146% unable to afford medical bills. . Inspite of treatment, there is significant reduction in the quality of the life of the patients. thus, increasing number of patients resort to AYUSH systems of medicine for care. The present study is an effort to document the outcomes of Ayurveda clinical practice in the management of CKD, both in terms of objective and subjective parameters. this will serve as a reference for developing future hypothesis for conducting large scale clinical trials.
|